Strides Pharma to manufacture Pfizer’s Covid-19 drug
The drug consists of Nirmatrelvir tablets, which are co-packaged and co-administered with Ritonavir tablets. Strides Pharma Science on Monday announced a sub-licensing agreement with the Medicines Patent Pool (MPP) to commercialise a generic version of Pfizer’s Covid-19 oral treatment in 95 low and middle-income markets. Pfizer’s Covid-19 oral treatment has received the US Food and … Read more